CHINA PHARMA HOLDINGS, INC. Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses
CHINA PHARMA HOLDINGS, INC. (CPHI) had Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses of $9.69 million as of 2025-12-31, per its 10-K filed 2026-04-01.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense › Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals
us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses · last filed 2026-04-01
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses $9.69M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses $9.48M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses $9.62M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses $9.78M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses |
|---|---|
| 2025-12-31 | $9.69M 10-K · filed 2026-04-01 |
| 2024-12-31 | $9.48M 10-K · filed 2026-04-01 |
| 2023-12-31 | $9.62M 10-K · filed 2025-03-31 |
| 2022-12-31 | $9.78M 10-K · filed 2024-04-01 |
| 2021-12-31 | $10.69M 10-K · filed 2023-03-30 |
| 2020-12-31 | $10.44M 10-K · filed 2022-03-30 |
| 2019-12-31 | $9.77M 10-K · filed 2021-03-26 |
| 2018-12-31 | $5.63M 10-K · filed 2020-03-30 |
| 2017-12-31 | $4.39M 10-K · filed 2019-03-28 |
| 2016-12-31 | $793.62K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |